Belgium· BE-AMP-SAM295163-00

Midazolam B. Braun 5 mg/ml

A midazolam product containing midazolam hydrochloride, registered in Belgium by B. Braun Melsungen. The same ATC class is registered in 14 of our 19 countries.

ATC N05CD08

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about midazolam hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Midazolam is registered in 14 of 19 countries.

Countries holding a registration under ATC N05CD08 (midazolam), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search midazolam products by name

Midazolam · ATC N05CD08

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of midazolam costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.55 in Switzerland to $4.74 in Finland — a ×8.6 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Midazolam · price per daily dose (5 mg)

USD · FX 28 Sept 2026

FI Finland$4.74
CH Switzerland$0.55

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Midazolam Hydrochloride
Manufacturer: B. Braun Melsungen
Country: Belgium (BE)
ATC code: N05CD08
ATC class: Midazolam
Defined daily dose: 5 mg, N
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
2476158
be_apb
0787473

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

316 interactions on record for midazolam.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check midazolam against other medicines How interaction checks work

Midazolam · interactions on record

316 records

9 severe
156 moderate
34 minor
57 info

Most severe, free to view

KetoconazoleH02CA03severe
KetoconazoleJ02AB02severe
FluconazoleJ02AC01severe
Darunavir and cobicistatJ05AR14severe

60 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Midazolam in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All midazolam products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Dormicum, Epistatus
Bulgaria · Midazolam Kalceks, Мидазолам Хамелн
Cyprus · Midazolam Accord, Midazolam B. Braun
Czechia · Dormicum, Midazolam Accord
Germany · Dormicum, Dormicum V
Denmark · Epistatus, Midazolam "hameln"
Estonia · Midazolam Kalceks
Spain · Dormicum, Midazolam Accord
Finland · Dormicum, Epistatus
France · Hypnovel, Midazolam Accord
United Kingdom (Northern Ireland) · Hypnovel, Midazolam Accord Healthcare
Greece · Dormicum, Dormipnol
Croatia · Dormicum, Midazolam B. Braun
Hungary · Dormicum, Epistatus
Ireland · Epistatus, Hypnovel
Iceland · Buccolam, Midazolam Accord
Italy · Epistatus, Midazolam Accord Healthcare
Liechtenstein · Buccolam
Lithuania · Fulsed, Midazolam B. Braun
Luxembourg · Midazolam Aguettant, Midazolam B. Braun
Latvia · Fulsed, Midazolam B. Braun
Malta · Midazolam Bp Accord Healthcare, Miprosed
Netherlands · Dormicum, Midazolam Accord
Norway · Buccolam, Epistatus
Poland · Dormicum, Epistatus
Portugal · Dormicum, Midazolam Accord
Romania · Midazolam Desitin, Midazolam Hameln
Sweden · Epistatus, Midazolam Accord
Slovenia · Dormicum, Epistatus
Slovakia · Midazolam Accord, Midazolam Hameln

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a9331341-70b4-41a7-94b8-e989e0bf00dd
GET /v1/drugs/a9331341-70b4-41a7-94b8-e989e0bf00dd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Midazolam B. Braun 5 mg/ml",
  "name_fr": "Midazolam B. Braun 5 mg/ml",
  "name_nl": "Midazolam B. Braun 5 mg/ml",
  "amp_code": "SAM295163-00",
  "strengths": [
    "5.5600",
    "5.0000",
    "5.6000"
  ],
  "pack_count": 2,
  "substances": [
    "Midazolam Hydrochloride",
    "Midazolam",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Midazolam",
  "authorisation_numbers": [
    "BE295163"
  ]
}

API reference MCP server Plans

See everything about midazolam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console